Rapport Therapeutics, Inc.

Q1 2026 13F Holders

Symbol: RAPP
CUSIP: 75383L102
Type: Equity
Class: COM
Num filings: 150
Total reported value, excl. options: $1.64 B

Compare 2026 Q1 to

Manager	Report Date	Value ($000)	Shares	Option Type